2025
SJR Q1
JCR Q1 · 9,2
455 matched articles
SCIE
Journal detail
Journal of the European Academy of Dermatology and Venereology
- Publisher
- John Wiley and Sons Inc
- Country
- United States · Northern America
- Type
- journal
- ISSN
-
0926995914683083
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 2,337
- Quartile Q1
- H-Index 154
- Cites/doc 3,1
- Docs (3y) 2.344
- Cites (3y) 7.189
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 9,2
- 5Y JIF 7,8
- JCI 2,32
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Dermatology Q1
- Infectious Diseases Q1
Areas
- Medicine
WoS categories
- Dermatology
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q1 | 2,337 | 9,2 | 7,8 | 2,32 | Q1 | 154 |
| 2024 | Q1 | Q1 | 2,154 | 8 | 7,1 | 2,18 | Q1 | 144 |
| 2023 | Q1 | Q1 | 1,686 | 8,5 | 7,1 | 1,96 | Q1 | 144 |
| 2022 | Q1 | Q1 | 1,51 | 9,2 | 7,2 | 1,73 | Q1 | 144 |
| 2021 | Q1 | Q1 | 1,613 | 9,2 | 7,7 | 1,79 | Q1 | 144 |
| 2020 | Q1 | Q1 | 1,655 | 6,2 | 6 | 1,71 | Q1 | 144 |
| 2019 | Q1 | Q1 | 1,45 | 5,2 | 4,6 | 1,72 | Q1 | 144 |
| 2018 | — | Q1 | — | 5,1 | 4,2 | 1,68 | Q1 | — |
| 2017 | Q1 | Q1 | 1,831 | 4,3 | 3,7 | 1,63 | Q1 | 144 |
| 2016 | Q1 | Q1 | 1,529 | 3,5 | 3,3 | — | — | 144 |
| 2015 | Q1 | Q1 | 1,492 | 3 | 2,9 | — | — | 144 |
| 2014 | Q1 | Q1 | 1,386 | 2,8 | 3 | — | — | 144 |
| 2013 | Q1 | Q1 | 1,485 | 3,1 | 3,1 | — | — | 144 |
| 2012 | Q1 | Q1 | 1,411 | 2,7 | 3 | — | — | 144 |
| 2011 | Q1 | Q1 | 1,305 | 3 | 2,8 | — | — | 144 |
| 2010 | Q1 | Q1 | 1,169 | 3,3 | 2,8 | — | — | 144 |
| 2009 | — | Q1 | — | 2,8 | 2,4 | — | — | — |
| 2008 | — | Q2 | — | 2,3 | 2,1 | — | — | — |
| 2007 | — | Q2 | — | 1,4 | 1,6 | — | — | — |
| 2006 | — | Q2 | — | 1,5 | — | — | — | — |
| 2005 | — | Q2 | — | 1,6 | — | — | — | — |
| 2004 | — | Q2 | — | 1,4 | — | — | — | — |
| 2003 | — | Q2 | — | 1,4 | — | — | — | — |
| 2002 | — | Q2 | — | 1 | — | — | — | — |
| 2001 | — | Q3 | — | 1 | — | — | — | — |
| 2000 | — | Q3 | — | 0,7 | — | — | — | — |
| 1999 | — | Q4 | — | 0,5 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | DERMATOLOGY | SCIE | Q1 | Q1 | 5/99 |
| 2024 | DERMATOLOGY | SCIE | Q1 | Q1 | 6/96 |
| 2023 | DERMATOLOGY | SCIE | Q1 | Q1 | 5/94 |
| 2022 | DERMATOLOGY | SCIE | Q1 | Q1 | 4/70 |
| 2021 | DERMATOLOGY | SCIE | Q1 | Q1 | 4/69 |
| 2020 | DERMATOLOGY | SCIE | Q1 | Q1 | 7/69 |
| 2019 | DERMATOLOGY | SCIE | Q1 | Q1 | 5/68 |
| 2018 | DERMATOLOGY | SCIE | Q1 | Q1 | 6/66 |
| 2017 | DERMATOLOGY | SCIE | Q1 | Q1 | 7/64 |
| 2016 | DERMATOLOGY | SCIE | Q1 | — | 9/63 |
| 2015 | DERMATOLOGY | SCIE | Q1 | — | 10/61 |
| 2014 | DERMATOLOGY | SCIE | Q1 | — | 11/63 |
| 2013 | DERMATOLOGY | SCIE | Q1 | — | 10/61 |
| 2012 | DERMATOLOGY | SCIE | Q1 | — | 13/59 |
| 2011 | DERMATOLOGY | SCIE | Q1 | — | 11/58 |
| 2010 | DERMATOLOGY | SCIE | Q1 | — | 10/55 |
| 2009 | DERMATOLOGY | SCIE | Q1 | — | 11/48 |
| 2008 | DERMATOLOGY | SCIE | Q2 | — | 13/43 |
| 2007 | DERMATOLOGY | SCIE | Q2 | — | 20/41 |
| 2006 | DERMATOLOGY | SCIE | Q2 | — | 18/39 |
| 2005 | DERMATOLOGY | SCIE | Q2 | — | 14/39 |
| 2004 | DERMATOLOGY | SCIE | Q2 | — | 13/38 |
| 2003 | DERMATOLOGY | SCIE | Q2 | — | 16/38 |
| 2002 | DERMATOLOGY & VENEREAL DISEASES | SCIE | Q2 | — | 20/40 |
| 2001 | DERMATOLOGY & VENEREAL DISEASES | SCIE | Q3 | — | 20/38 |
| 2000 | DERMATOLOGY & VENEREAL DISEASES | SCIE | Q3 | — | 26/36 |
| 1999 | DERMATOLOGY & VENEREAL DISEASES | SCIE | Q4 | — | 29/36 |